14. Supplemental Consolidating Financial Information

RTS’ payment obligations under the senior secured credit facility, senior secured second lien notes, and senior subordinated notes are guaranteed by Radiation Therapy Services Holdings, Inc. (“Parent”), which owns 100% of RTS and certain domestic subsidiaries of RTS, all of which are, directly or indirectly, 100% owned by RTS (the “Subsidiary Guarantors” and, collectively with Parent, the “Guarantors”). Such guarantees are full, unconditional and joint and several. The consolidated joint ventures, foreign subsidiaries and professional corporations of the Company are non-guarantors. The following supplemental financial information sets forth, on an unconsolidated basis, balance sheets, statements of operations and comprehensive income (loss), and statements of cash flows information for Parent, RTS, the Subsidiary Guarantors and the non-guarantor subsidiaries. The supplemental financial information reflects the investment of Parent and RTS and subsidiary guarantors using the equity method of accounting.

CONSOLIDATING BALANCE SHEETS (UNAUDITED)

as of June 30, 2013

(in thousands)

	Parent			RTS			Subsidiary Guarantors			Subsidiary Non-Guarantors		Eliminations			Consolidated
ASSETS
Current assets:
Cash and cash equivalents	$	151		$	291		$	139		$	11,178	$	—		$	11,759
Restricted cash	—			5,001			—			—		—			5,001
Accounts receivable, net	—			—			48,548			42,321		—			90,869
Intercompany receivables	1,442			—			105,654			—		(107,096		)	—
Prepaid expenses	—			167			6,628			588		—			7,383
Inventories	—			—			3,676			689		—			4,365
Deferred income taxes	(68		)	(2,699		)	3,020			557		—			810
Other	—			247			5,554			33		—			5,834
Total current assets	1,525			3,007			173,219			55,366		(107,096		)	126,021
Equity investments in joint ventures	(45,130		)	797,725			105,552			51		(857,417		)	781
Property and equipment, net	—			—			188,063			36,651		—			224,714
Real estate subject to finance obligation	—			—			20,465			—		—			20,465
Goodwill	—			—			430,162			74,140		—			504,302
Intangible assets, net	—			—			13,892			19,905		—			33,797
Other assets	—			19,351			12,754			8,590		—			40,695
Intercompany note receivable	—			3,850			628			—		(4,478		)	—
Total assets	$	(43,605	)	$	823,933		$	944,735		$	194,703	$	(968,991	)	$	950,775
LIABILITIES AND EQUITY
Current liabilities:
Accounts payable	$	—		$	140		$	28,643		$	6,478	$	—		$	35,261
Intercompany payables	—			93,862			—			13,234		(107,096		)	—
Accrued expenses	—			11,724			32,698			6,461		—			50,883
Income taxes payable	(1,272		)	2,726			(305		)	1,178		—			2,327
Current portion of long-term debt	—			—			8,819			4,088		—			12,907
Current portion of finance obligation	—			—			283			—		—			283
Other current liabilities	—			—			4,820			3,805		—			8,625
Total current liabilities	(1,272		)	108,452			74,958			35,244		(107,096		)	110,286
Long-term debt, less current portion	—			773,419			24,622			987		—			799,028
Finance obligation, less current portion	—			—			21,839			—		—			21,839
Other long-term liabilities	—			—			17,730			6,220		—			23,950
Deferred income taxes	(156		)	(12,808		)	15,958			2,599		—			5,593
Intercompany note payable	—			—			—			4,478		(4,478		)	—
Total liabilities	(1,428		)	869,063			155,107			49,528		(111,574		)	960,696
Noncontrolling interests—redeemable	—			—			—			—		16,350			16,350
Total Radiation Therapy Services Holdings, Inc. shareholder’s (deficit) equity	(42,177		)	(45,130		)	789,628			145,175		(889,673		)	(42,177		)
Noncontrolling interests—nonredeemable	—			—			—			—		15,906			15,906
Total (deficit) equity	(42,177		)	(45,130		)	789,628			145,175		(873,767		)	(26,271		)
Total liabilities and (deficit) equity	$	(43,605	)	$	823,933		$	944,735		$	194,703	$	(968,991	)	$	950,775

CONSOLIDATING STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) (UNAUDITED)

Three Months Ended June 30, 2013

(in thousands)

	Parent			RTS			Subsidiary Guarantors			Subsidiary Non-Guarantors			Eliminations			Consolidated
Revenues:
Net patient service revenue	$	—		$	—		$	115,026		$	60,821		$	—		$	175,847
Other revenue	—			—			2,390			80			—			2,470
(Loss) income from equity investment	(23,032		)	(3,104		)	(2,620		)	(2		)	28,550			(208		)
Intercompany revenue	—			202			19,669			—			(19,871		)	—
Total revenues	(23,032		)	(2,902		)	134,465			60,899			8,679			178,109
Expenses:
Salaries and benefits	155			—			76,510			23,022			—			99,687
Medical supplies	—			—			12,290			2,117			—			14,407
Facility rent expenses	—			—			9,006			1,669			—			10,675
Other operating expenses	—			—			7,436			3,561			—			10,997
General and administrative expenses	—			312			18,570			4,279			—			23,161
Depreciation and amortization	—			—			13,287			2,033			—			15,320
Provision for doubtful accounts	—			—			1,049			966			—			2,015
Interest expense, net	—			19,592			805			76			—			20,473
Gain on the sale of an interest in a joint venture	—			—			(1,460		)	—			—			(1,460		)
Loss on foreign currency transactions	—			—			—			758			—			758
Loss on foreign currency derivative contracts	—			190			—			—			—			190
Intercompany expenses	—			—			—			19,871			(19,871		)	—
Total expenses	155			20,094			137,493			58,352			(19,871		)	196,223
(Loss) income before income taxes	(23,187		)	(22,996		)	(3,028		)	2,547			28,550			(18,114		)
Income tax expense	—			36			—			1,335			—			1,371
Net (loss) income	(23,187		)	(23,032		)	(3,028		)	1,212			28,550			(19,485		)
Net income attributable to noncontrolling interests—redeemable and non-redeemable	—			—			—			—			(654		)	(654		)
Net (loss) income attributable to Radiation Therapy Services Holdings, Inc. shareholder	(23,187		)	(23,032		)	(3,028		)	1,212			27,896			(20,139		)
Unrealized comprehensive loss:	—			—			—			(3,408		)	—			(3,408		)
Comprehensive loss	(23,187		)	(23,032		)	(3,028		)	(2,196		)	28,550			(22,893		)
Comprehensive income attributable to noncontrolling interests-redeemable and non-redeemable:	—			—			—			—			(294		)	(294		)
Comprehensive loss attributable to Radiation Therapy Services Holdings, Inc. shareholder	$	(23,187	)	$	(23,032	)	$	(3,028	)	$	(2,196	)	$	28,256		$	(23,187	)

CONSOLIDATING STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) (UNAUDITED)

Six Months Ended June 30, 2013

(in thousands)

	Parent			RTS			Subsidiary Guarantors			Subsidiary Non-Guarantors			Eliminations			Consolidated
Revenues:
Net patient service revenue	$	—		$	—		$	227,963		$	119,857		$	—		$	347,820
Other revenue	—			—			4,526			72			—			4,598
(Loss) income from equity investment	(44,596		)	(5,234		)	(3,139		)	7			52,630			(332		)
Intercompany revenue	—			375			38,615			—			(38,990		)	—
Total revenues	(44,596		)	(4,859		)	267,965			119,936			13,640			352,086
Expenses:
Salaries and benefits	346			—			150,072			45,522			—			195,940
Medical supplies	—			—			25,746			4,503			—			30,249
Facility rent expenses	—			—			17,603			3,255			—			20,858
Other operating expenses	—			—			14,569			6,704			—			21,273
General and administrative expenses	—			639			35,506			7,751			—			43,896
Depreciation and amortization	—			—			26,484			4,007			—			30,491
Provision for doubtful accounts	—			—			2,993			2,097			—			5,090
Interest expense, net	—			38,818			1,457			142			—			40,417
Gain on the sale of an interest in a joint venture	—			—			(1,460		)	—			—			(1,460		)
Loss on foreign currency transactions	—			—			—			802			—			802
Loss on foreign currency derivative contracts	—			242			—			—			—			242
Intercompany expenses	—			—			—			38,990			(38,990		)	—
Total expenses	346			39,699			272,970			113,773			(38,990		)	387,798
(Loss) income before income taxes	(44,942		)	(44,558		)	(5,005		)	6,163			52,630			(35,712		)
Income tax (benefit) expense	—			38			—			3,112			—			3,150
Net (loss) income	(44,942		)	(44,596		)	(5,005		)	3,051			52,630			(38,862		)
Net income attributable to noncontrolling interests—redeemable and non-redeemable	—			—			—			—			(1,018		)	(1,018		)
Net (loss) income attributable to Radiation Therapy Services Holdings, Inc. shareholder	(44,942		)	(44,596		)	(5,005		)	3,051			51,612			(39,880		)
Unrealized comprehensive loss:	—			—			—			(5,589		)	—			(5,589		)
Comprehensive loss	(44,942		)	(44,596		)	(5,005		)	(2,538		)	52,630			(44,451		)
Comprehensive income attributable to noncontrolling interests-redeemable and non-redeemable:	—			—			—			—			(491		)	(491		)
Comprehensive loss attributable to Radiation Therapy Services Holdings, Inc. shareholder	$	(44,942	)	$	(44,596	)	$	(5,005	)	$	(2,538	)	$	52,139		$	(44,942	)

CONSOLIDATING STATEMENT OF CASH FLOWS (UNAUDITED)

Six Months Ended June 30, 2013

(in thousands)

	Parent			RTS			Subsidiary Guarantors			Subsidiary Non-Guarantors			Eliminations			Consolidated
Cash flows from operating activities
Net (loss) income	$	(44,942	)	$	(44,596	)	$	(5,005	)	$	3,051		$	52,630		$	(38,862	)
Adjustments to reconcile net (loss) income to net cash provided by (used in) operating activities:
Depreciation	—			—			22,928			3,294			—			26,222
Amortization	—			—			3,556			713			—			4,269
Deferred rent expense	—			—			324			98			—			422
Deferred income taxes	—			(240		)	230			(1,128		)	—			(1,138		)
Stock-based compensation	345			—			—			—			—			345
Provision for doubtful accounts	—			—			2,993			2,097			—			5,090
Loss on the sale of property and equipment	—			—			40			36			—			76
Gain on the sale of an interest in a joint venture	—			—			(1,460		)	—			—			(1,460		)
Loss on foreign currency transactions	—			—			—			34			—			34
Loss on foreign currency derivative contracts	—			242			—			—			—			242
Amortization of debt discount	—			381			10			—			—			391
Amortization of loan costs	—			2,731			—			—			—			2,731
Equity interest in net loss (earnings) of joint ventures	44,596			5,234			3,139			(7		)	(52,630		)	332
Changes in operating assets and liabilities:
Accounts receivable and other current assets	—			—			(1,978		)	(7,699		)	—			(9,677		)
Income taxes payable	1			1,179			(1,567		)	126			—			(261		)
Inventories	—			—			(632		)	171			—			(461		)
Prepaid expenses	—			(77		)	(96		)	219			—			46
Intercompany payable / receivable	(17		)	914			(3,605		)	2,708			—			—
Accounts payable and other current liabilities	—			(232		)	7,953			1,101			—			8,822
Accrued deferred compensation	—			—			524			132			—			656
Accrued expenses / other current liabilities	—			(355		)	7,384			(1,234		)	—			5,795
Net cash (used in) provided by operating activities	(17		)	(34,819		)	34,738			3,712			—			3,614
Cash flows from investing activities
Purchases of property and equipment	—			—			(14,928		)	(2,841		)	—			(17,769		)
Acquisition of medical practices	—			—			(22,848		)	—			—			(22,848		)
Restricted cash associated with initial deposit in the potential acquisition of medical practices	—			(5,001		)	—			—			—			(5,001		)
Proceeds from the sale of property and equipment	—			—			4			—			—			4
Loans to employees	—			—			(153		)	—			—			(153		)
Intercompany notes to / from affiliates	—			(2,100		)	(396		)	2,496			—			—
Contribution of capital to joint venture entities	—			(542		)	(935		)	—			935			(542		)
Distributions received from joint venture entities	—			299			776			—			(1,075		)	—
Proceeds from the sale of equity interest in a joint venture	—			—			1,460			—			—			1,460
Payment of foreign currency derivative contracts	—			(171		)	—			—			—			(171		)
Premiums on life insurance policies	—			—			(493		)	(133		)	—			(626		)
Change in other assets and other liabilities	—			1			(6		)	10			—			5
Net cash used in by investing activities	—			(7,514		)	(37,519		)	(468		)	(140		)	(45,641		)
Cash flows from financing activities
Proceeds from issuance of debt	—			82,500			—			1,380			—			83,880
Principal repayments of debt	—			(40,000		)	(3,526		)	(1,975		)	—			(45,501		)
Repayments of finance obligation	—			—			(99		)	—			—			(99		)
Proceeds from equity contribution	—			—			—			1,700			(1,700		)	—
Proceeds from noncontrolling interest holders — redeemable and non-redeemable	—			—			—			—			765			765
Cash distributions to noncontrolling interest holders—redeemable and non-redeemable	—			—			—			—			(650		)	(650		)
Cash distributions to shareholders	—			—			—			(1,725		)	1,725			—
Net cash (used in) provided by financing activities	—			42,500			(3,625		)	(620		)	140			38,395
Effect of exchange rate changes on cash and cash equivalents	—			—			—			(19		)	—			(19		)
Net (decrease) increase in cash and cash equivalents	(17		)	167			(6,406		)	2,605			—			(3,651		)
Cash and cash equivalents, beginning of period	168			124			6,545			8,573			—			15,410
Cash and cash equivalents, end of period	$	151		$	291		$	139		$	11,178		$	—		$	11,759

CONSOLIDATING BALANCE SHEETS

as of December 31, 2012

(in thousands)

	Parent			RTS			Subsidiary Guarantors		Subsidiary Non-Guarantors		Eliminations			Consolidated
ASSETS
Current assets:
Cash and cash equivalents	$	168		$	124		$	6,545	$	8,573	$	—		$	15,410
Accounts receivable, net	—			—			47,231		39,638		—			86,869
Intercompany receivables	1,425			—			101,763		—		(103,188		)	—
Prepaid expenses	—			90			5,320		633		—			6,043
Inventories	—			—			3,241		656		—			3,897
Deferred income taxes	(68		)	(2,697		)	3,017		288		—			540
Other	—			319			7,065		45		—			7,429
Total current assets	1,525			(2,164		)	174,182		49,833		(103,188		)	120,188
Equity investments in joint ventures	(534		)	802,705			102,230		49		(903,875		)	575
Property and equipment, net	—			—			186,084		34,966		—			221,050
Real estate subject to finance obligation	—			—			16,204		—		—			16,204
Goodwill	—			—			413,984		71,875		—			485,859
Intangible assets, net	—			—			15,555		19,489		—			35,044
Other assets	—			22,082			13,236		8,063		—			43,381
Intercompany note receivable	—			1,750			232		—		(1,982		)	—
Total assets	$	991		$	824,373		$	921,707	$	184,275	$	(1,009,045	)	$	922,301
LIABILITIES AND EQUITY
Current liabilities:
Accounts payable	$	—		$	372		$	20,690	$	6,476	$	—		$	27,538
Intercompany payables	—			92,937			—		10,251		(103,188		)	—
Accrued expenses	—			12,079			26,017		8,305		—			46,401
Income taxes payable	(1,273		)	1,547			1,262		1,415		—			2,951
Current portion of long-term debt	—			—			6,424		4,641		—			11,065
Current portion of finance obligation	—			—			287		—		—			287
Other current liabilities	—			—			3,940		3,744		—			7,684
Total current liabilities	(1,273		)	106,935			58,620		34,832		(103,188		)	95,926
Long-term debt, less current portion	—			730,538			19,561		1,204		—			751,303
Finance obligation, less current portion	—			—			16,905		—		—			16,905
Other long-term liabilities	—			—			16,272		5,858		—			22,130
Deferred income taxes	(156		)	(12,566		)	15,726		3,198		—			6,202
Intercompany note payable	—			—			—		1,982		(1,982		)	—
Total liabilities	(1,429		)	824,907			127,084		47,074		(105,170		)	892,466
Noncontrolling interests—redeemable	—			—			—		—		11,368			11,368
Total Radiation Therapy Services Holdings, Inc. shareholder’s equity (deficit)	2,420			(534		)	794,623		137,201		(931,290		)	2,420
Noncontrolling interests—nonredeemable	—			—			—		—		16,047			16,047
Total equity	2,420			(534		)	794,623		137,201		(915,243		)	18,467
Total liabilities and equity	$	991		$	824,373		$	921,707	$	184,275	$	(1,009,045	)	$	922,301

CONSOLIDATING STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) (UNAUDITED)

Three Months Ended June 30, 2012

(in thousands)

	Parent			RTS			Subsidiary Guarantors			Subsidiary Non-Guarantors			Eliminations			Consolidated
Revenues:
Net patient service revenue	$	—		$	—		$	117,174		$	61,325		$	—		$	178,499
Other revenue	—			—			1,859			54			—			1,913
(Loss) income from equity investment	(21,436		)	5,390			425			(2		)	15,465			(158		)
Intercompany revenue	—			448			19,586			—			(20,034		)	—
Total revenues	(21,436		)	5,838			139,044			61,377			(4,569		)	180,254
Expenses:
Salaries and benefits	2,917			—			70,563			21,686			—			95,166
Medical supplies	—			—			13,296			3,343			—			16,639
Facility rent expenses	—			—			8,364			1,561			—			9,925
Other operating expenses	—			—			6,634			3,327			—			9,961
General and administrative expenses	—			420			17,499			3,382			—			21,301
Depreciation and amortization	—			928			13,315			2,004			—			16,247
Provision for doubtful accounts	—			—			3,943			857			—			4,800
Interest expense, net	6			18,810			694			90			—			19,600
Early extinguishment of debt	—			4,473			—			—			—			4,473
Foreign currency transaction loss	—			—			—			45			—			45
Gain on foreign currency derivative contracts	—			(374		)	—			—			—			(374		)
Intercompany expenses	—			(118		)	—			20,152			(20,034		)	—
Total expenses	2,923			24,139			134,308			56,447			(20,034		)	197,783
(Loss) income before income taxes	(24,359		)	(18,301		)	4,736			4,930			15,465			(17,529		)
Income tax (benefit) expense	(1,996		)	3,135			(416		)	722			(6		)	1,439
Net (loss) income	(22,363		)	(21,436		)	5,152			4,208			15,471			(18,968		)
Net income attributable to noncontrolling interests—redeemable and non-redeemable	—			—			—			—			(1,236		)	(1,236		)
Net (loss) income attributable to Radiation Therapy Services Holdings, Inc. shareholder	(22,363		)	(21,436		)	5,152			4,208			14,235			(20,204		)
Unrealized comprehensive loss:	—			—			—			(2,492		)	—			(2,492		)
Comprehensive (loss) income	(22,363		)	(21,436		)	5,152			1,716			15,471			(21,460		)
Comprehensive income attributable to noncontrolling interests-redeemable and non-redeemable:	—			—			—			—			(903		)	(903		)
Comprehensive (loss) income attributable to Radiation Therapy Services Holdings, Inc. shareholder	$	(22,363	)	$	(21,436	)	$	5,152		$	1,716		$	14,568		$	(22,363	)

CONSOLIDATING STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) (UNAUDITED)

Six Months Ended June 30, 2012

(in thousands)

	Parent			RTS			Subsidiary Guarantors			Subsidiary Non-Guarantors			Eliminations			Consolidated
Revenues:
Net patient service revenue	$	—		$	—		$	233,833		$	120,214		$	—		$	354,047
Other revenue	—			—			3,993			198			—			4,191
(Loss) income from equity investment	(31,776		)	12,162			1,382			10			17,683			(539		)
Intercompany revenue	—			479			37,276			—			(37,755		)	—
Total revenues	(31,776		)	12,641			276,484			120,422			(20,072		)	357,699
Expenses:
Salaries and benefits	3,012			—			142,658			43,339			—			189,009
Medical supplies	—			—			25,924			6,175			—			32,099
Facility rent expenses	—			—			16,487			3,028			—			19,515
Other operating expenses	—			—			12,731			5,931			—			18,662
General and administrative expenses	—			694			33,093			7,196			—			40,983
Depreciation and amortization	—			1,855			25,746			3,842			—			31,443
Provision for doubtful accounts	—			—			6,925			2,936			—			9,861
Interest expense, net	5			35,598			1,349			203			—			37,155
Early extinguishment of debt	—			4,473			—			—			—			4,473
Foreign currency transaction loss	—			—			—			94			—			94
Loss on foreign currency derivative contracts	—			220			—			—			—			220
Intercompany expenses	—			—			—			37,755			(37,755		)	—
Total expenses	3,017			42,840			264,913			110,499			(37,755		)	383,514
(Loss) income before income taxes	(34,793		)	(30,199		)	11,571			9,923			17,683			(25,815		)
Income tax (benefit) expense	(1,996		)	1,244			(324		)	2,638			(13		)	1,549
Net (loss) income	(32,797		)	(31,443		)	11,895			7,285			17,696			(27,364		)
Net income attributable to noncontrolling interests—redeemable and non-redeemable	—			—			—			—			(2,389		)	(2,389		)
Net (loss) income attributable to Radiation Therapy Services Holdings, Inc. shareholder	(32,797		)	(31,443		)	11,895			7,285			15,307			(29,753		)
Unrealized comprehensive loss:	—			(333		)	—			(3,020		)	—			(3,353		)
Comprehensive (loss) income	(32,797		)	(31,776		)	11,895			4,265			17,696			(30,717		)
Comprehensive income attributable to noncontrolling interests-redeemable and non-redeemable:	—			—			—			—			(2,080		)	(2,080		)
Comprehensive (loss) income attributable to Radiation Therapy Services Holdings, Inc. shareholder	$	(32,797	)	$	(31,776	)	$	11,895		$	4,265		$	15,616		$	(32,797	)

CONSOLIDATING STATEMENT OF CASH FLOWS (UNAUDITED)

Six Months Ended June 30, 2012

(in thousands)

	Parent			RTS			Subsidiary Guarantors			Subsidiary Non-Guarantors			Eliminations			Consolidated
Cash flows from operating activities
Net (loss) income	$	(32,797	)	$	(31,443	)	$	11,895		$	7,285		$	17,696		$	(27,364	)
Adjustments to reconcile net (loss) income to net cash provided by (used in) operating activities:
Depreciation	—			—			22,555			3,082			—			25,637
Amortization	—			1,855			3,191			760			—			5,806
Deferred rent expense	—			—			425			124			—			549
Deferred income taxes	—			(77		)	81			(693		)	(13		)	(702		)
Stock-based compensation	3,012			—			—			—			—			3,012
Provision for doubtful accounts	—			—			6,925			2,936			—			9,861
Loss on the sale of property and equipment	—			—			22			—			—			22
Amortization of termination of interest rate swap	—			958			—			—			—			958
Write-off of loan costs	—			525			—			—			—			525
Early extinguishment of debt	—			4,473			—			—			—			4,473
Termination of derivative interest rate swap agreements	—			(972		)	—			—			—			(972		)
Loss on foreign currency transactions	—			—			—			18			—			18
Loss on foreign currency derivative contracts	—			220			—			—			—			220
Amortization of debt discount	—			417			—			—			—			417
Amortization of loan costs	—			2,609			—			—			—			2,609
Equity interest in net loss (earnings) of joint ventures	31,776			(12,162		)	(1,382		)	(10		)	(17,683		)	539
Distribution received from unconsolidated joint ventures	—			—			9			—			—			9
Changes in operating assets and liabilities:
Accounts receivable and other receivables	3			—			(10,822		)	(7,283		)	—			(18,102		)
Income taxes payable	—			1,299			(1,298		)	(442		)	—			(441		)
Inventories	—			—			(453		)	(260		)	—			(713		)
Prepaid expenses	—			(102		)	950			263			—			1,111
Intercompany payable / receivable	(2,133		)	(31,414		)	27,780			5,767			—			—
Accounts payable and other current liabilities	—			92			(2,460		)	(333		)	—			(2,701		)
Accrued deferred compensation	—			—			513			89			—			602
Accrued expenses	—			4,610			1,613			91			—			6,314
Net cash (used in) provided by operating activities	(139		)	(59,112		)	59,544			11,394			—			11,687
Cash flows from investing activities
Purchases of property and equipment	—			—			(13,609		)	(2,689		)	—			(16,298		)
Acquisition of medical practices	—			—			(23,692		)	(50		)	—			(23,742		)
Proceeds from the sale of property and equipment	—			—			27			—			—			27
Loans to employees	—			—			(115		)	—			—			(115		)
Intercompany notes to / from affiliates	—			—			—			—			—			—
Contribution of capital to joint venture entities	—			—			(225		)	—			—			(225		)
Distributions received from joint venture entities	—			754			3,043			—			(3,797		)	—
Payment of foreign currency derivative contracts	—			(432		)	—			—			—			(432		)
Premiums on life insurance policies	—			—			—			(518		)	—			(518		)
Change in other assets and other liabilities	—			1			(32		)	38			—			7
Net cash (used in) provided by investing activities	—			323			(34,603		)	(3,219		)	(3,797		)	(41,296		)
Cash flows from financing activities
Proceeds from issuance of debt	—			433,345			—			716			—			434,061
Principal repayments of debt	—			(360,360		)	(7,969		)	(1,574		)	—			(369,903		)
Repayments of finance obligation	—			—			(53		)	—			—			(53		)
Cash distributions to noncontrolling interest holders—redeemable and non-redeemable	—			—			—			—			(2,018		)	(2,018		)
Payment of loan costs	—			(14,225		)	—			—			—			(14,225		)
Cash distributions to shareholders	—			—			—			(5,815		)	5,815			—
Net cash provided by (used in) financing activities	—			58,760			(8,022		)	(6,673		)	3,797			47,862
Effect of exchange rate changes on cash and cash equivalents	—			—			—			(5		)	—			(5		)
Net (decrease) increase in cash and cash equivalents	(139		)	(29		)	16,919			1,497			—			18,248
Cash and cash equivalents, beginning of period	184			39			733			9,221			—			10,177
Cash and cash equivalents, end of period	$	45		$	10		$	17,652		$	10,718		$	—		$	28,425